Why Alopecia Areata Is Fundamentally Different from Pattern Baldness

In androgenetic alopecia, follicles miniaturize due to DHT sensitivity but remain in place — they can be moved and will continue producing hair. The donor area is resistant to DHT and provides stable grafts. In alopecia areata, the immune system attacks follicles regardless of their location. There is no inherently 'stable' donor area — if the autoimmune condition is active, newly transplanted follicles may be attacked just as native follicles were.

When Hair Transplants May Be Appropriate for Alopecia Patients

The clinical consensus is that hair transplants may be considered when: the condition has been stable for a minimum of 1-2 years, the patches represent permanent bald areas rather than areas that may regrow spontaneously, donor area follicles show no signs of miniaturization, and the patient has realistic expectations about the risk of recurrence.

New Medical Options That May Eliminate the Need for Surgery

The FDA approved baricitinib (Olumiant) in 2022 and ritlecitinib (Litfulo) in 2023 specifically for alopecia areata — the first targeted treatments for this condition. These JAK inhibitors work by interrupting the immune pathway that attacks hair follicles. Clinical trials show meaningful hair regrowth in significant proportions of patients.

The Risk of Koebnerization

Koebnerization refers to the phenomenon where trauma to the skin triggers the underlying condition in that location. In alopecia areata, some patients experience koebnerization — meaning the surgical trauma of hair transplantation may trigger new alopecia patches in the recipient or donor area.

Our Guidance for Alopecia Areata Patients

Do not seek hair transplantation as the first response to alopecia areata. See a dermatologist first. Explore medical treatment options including JAK inhibitors before any surgical discussion. If the condition is stable and medical options have been exhausted, then pursue a surgical consultation with a specialist who has documented alopecia areata experience.